Document:

agen-ex101_148.htm

Exhibit 10.1

 

AMENDMENT NO. 1 TO

CONSULTING AGREEMENT

This AMENDMENT NO. 1 TO CONSULTING AGREEMENT (this “Amendment”), effective as of July 1, 2018 (the “Amendment Effective Date”), is by and between Agenus Inc., a Delaware corporation having an address at 149 Fifth Avenue, Suite 500, New York, NY 10010 (the “Company”), and Dr. Robert Stein, an individual currently residing at 7 Peter Cooper Rd., Apt 10-B, New York, NY 10010 (the “Consultant”) (each a “Party” and together the “Parties”).  Capitalized terms used in this Amendment and not otherwise defined herein shall have those meanings attributed to them in the Agreement (as defined below).

WITNESSETH

 

WHEREAS, the Company and the Consultant are parties to that certain Consulting Agreement effective as of April 1, 2017 (the “Agreement”); and

 

WHEREAS, the Parties now wish to amend the Agreement as set forth herein.

 

NOW, THEREFORE, the Parties agree as follows:

	
 
	
1.
	
Section 1.1 of the Agreement is hereby deleted and replaced with the following:

 

“Description of Services. Subject to the terms and conditions of this Agreement, Agenus hereby retains Consultant as a Senior Advisor, Research & Development, to its CEO, Dr. Garo Armen, and/or his designees, to provide scientific guidance and advisory services to Agenus and/or its Affiliates, and such other services as may be requested from time to time (collectively, the “Services”).  Consultant shall make himself available to Agenus and/or its Affiliates for up to 20 hours per week, including providing updates to the CEO at least bi-weekly, and participating in Agenus research personnel meetings upon request of the CEO or his designee.  Consultant shall perform the Services promptly and in compliance with the provisions of this Agreement and all applicable laws, rules and regulations, including if applicable, laws and regulations administered by the U.S. Food and Drug Administration (“FDA”) regarding the promotion and marketing of pharmaceutical products.  Consultant shall ensure that the Services are performed promptly and diligently. As used in this Agreement “Affiliate” means any corporation, firm, partnership or other entity, which controls, is controlled by or is under common control with a Party.  As used in this Agreement, “control” means direct or indirect ownership of fifty percent (50%) or more of the outstanding stock or other voting rights entitled to elect directors thereof or the ability to otherwise control the management of the corporation, firm, partnership or other entity.”     

 

	
 
	
2.
	
Section 2.1 of the Agreement is hereby deleted and replaced with the following:

 

“Compensation.  In exchange for the timely completion of Services during the Term, Agenus shall pay to Consultant a monthly retainer of $25,000 (the “Compensation”), and Consultant shall be entitled to continuation of vesting during the Term with 

 

 

respect to all equity incentive awards held by Consultant as of the Amendment Effective Date.  In the event of a Change of Control (as defined in the Employment Agreement) during the Term, all vesting of Consultant’s stock options will immediately be accelerated in full.  All payments for Compensation shall be made within 15 days following the end of each month Services are performed.  All monies to be paid under this Agreement shall be paid to Consultant in U.S. Dollars.  Consultant acknowledges and agrees that payments made hereunder are for Services performed by Consultant.  No payments shall be passed through to third parties on behalf of Agenus without a valid invoice or other written documentation between the Parties evidencing such payment arrangement.”

 

	
 
	
3.
	
Section 3.1 of the Agreement is hereby deleted and replaced with the following:

 

“Term.  This Amendment shall commence on the Amendment Effective Date and shall remain in effect for a period of 12 months, unless extended by mutual written agreement of the Parties, or earlier terminated in accordance with the provisions of this Article 3 (such 12-month period as it may be extended or terminated, the “Term”).”

	
 
	
4.
	
Section 3.2 of the Agreement is hereby deleted and replaced with the following:

 

“Termination.

	
 
	
(a)
	
The Parties may mutually agree to terminate this Agreement at any time.

	
 
	
(b)
	
Agenus may terminate this Agreement immediately upon written notice to Consultant (or his legal representative) in the event (i) of the death or legal incapacity of Consultant; (ii) that Consultant is otherwise no longer able to perform the Services; or (iii) if Consultant breaches any provision of Sections 1.2, 1.3, 1.4, 1.5 or Articles 4, 5 or 6.

	
 
	
(c)
	
Either Party may terminate this Agreement for convenience at any time upon 90 days’ prior written notice.”

	
 
	
5.
	
Except as set forth in this Amendment, the Agreement shall remain in full force and effect.

 

	
 
	
6.
	
This Amendment may be executed in counterparts, which, when taken together, shall constitute one agreement. If any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

 

	
 
	
7.
	
This Amendment shall be governed by and construed in accordance with the laws of the State of New York irrespective of any conflicts of law principles thereof.

 

 

 

 

IN WITNESS WHEREOF, the Parties hereto have executed this Amendment as of the Amendment Effective Date.

 

		
	
AGENUS INC. 

 

 
	
CONSULTANT

	
By:/s/ Garo H. Armen_________

Name:  Garo H. Armen 

Title:    Chairman & CEO

 
	
/s/ Robert Stein_________

Name:  Dr. Robert Steinagen-ex102_147.htm

Exhibit 10.2

 

CONSULTING AGREEMENT

This Consulting Agreement (the “Agreement”), effective as of July 1, 2018 (the “Effective Date”), is made between AgenTus Therapeutics, Inc., a Delaware corporation, having an address at 3 Forbes Road, Lexington, MA 02421 (“AgenTus”), and Dr. Robert Stein, an individual currently residing at 7 Peter Cooper Rd., Apt 10-B, New York, NY 10010  (the “Consultant”) (each a “Party” and collectively the “Parties”).

WHEREAS, AgenTus desires to retain the services of Consultant, and Consultant desires to perform certain services for AgenTus;

NOW, THEREFORE, in consideration of the mutual covenants and promises contained herein and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, AgenTus and Consultant hereby agree as follows:

1.Services.

1.1Description of Services. Subject to the terms and conditions of this Agreement, AgenTus or its designee hereby retains Consultant to perform for AgenTus and/or potentially its Affiliates (as hereinafter defined) the services specified in one or more attachments (the “Attachment”) to this Agreement executed by the Parties (the “Services”).  Consultant shall perform the Services promptly and in compliance with the provisions of this Agreement and all applicable laws, rules and regulations, including if applicable, laws and regulations administered by the U.S. Food and Drug Administration (“FDA”) regarding the promotion and marketing of pharmaceutical products.  Consultant shall ensure that the Services are performed promptly and diligently.  

As used in this Agreement “Affiliate” means any corporation, firm, partnership or other entity, which controls, is controlled by or is under common control with a Party.  As used in this Agreement, “control” means direct or indirect ownership of fifty percent (50%) or more of the outstanding stock or other voting rights entitled to elect directors thereof or the ability to otherwise control the management of the corporation, firm, partnership or other entity.

1.2Non-Solicitation.  Consultant agrees that during the term of this Agreement and for a period of two (2) years thereafter, Consultant shall not, directly or indirectly, (i) solicit, divert, or take away, or attempt to divert or take away, the business or patronage of any actual or prospective clients, customers, or accounts of AgenTus, or (ii) recruit, solicit, or hire any employee of AgenTus, or induce or attempt to induce any employee of AgenTus, to discontinue his or her relationship with AgenTus.

1.3Third Party Obligations.  Consultant represents and warrants to AgenTus that none of his or her current obligations conflict with this Agreement or the Services to be provided hereunder.  Consultant covenants not to enter into any such conflicting agreement or incur any such conflicting obligation without the prior written consent of AgenTus.  Consultant further covenants that the performance of the Services will not breach any agreement or obligation with 

Page 1 of 10

 

any third party, including without limitation any obligation to refrain from engaging in activities that may compete with such party.

1.4No Disparagement; Moral Hazard Clause.  Consultant agrees that during the Term and thereafter, Consultant shall not disparage AgenTus or any of its Affiliates, or their respective directors, officers, employees, consultants, or agents, or otherwise make any statement or take any actions that would be materially harmful to the business, interests or reputation of AgenTus or any of its Affiliates, or their respective directors, officers, employees, consultants, or agents. Consultant further agrees that that during the Term and thereafter, Consultant shall not engage in any behavior that could adversely impact the reputation of Agenus, including but not limited to committing, or being arrested for or charged with, any crime, or committing any acts of moral turpitude.

2.Compensation.

2.1Compensation.  In exchange for the timely completion of Services during the Term, AgenTus shall pay to Consultant compensation as set forth in the applicable Attachment.  Fees will be paid upon documented completion of Service in accordance with the requirements set forth in the Attachment. All compensation and expense reimbursements to be paid under this Agreement shall be paid to Consultant in the currency set forth in the applicable Attachment.  Consultant acknowledges and agrees that payments made hereunder are for Services performed by Consultant.  No payments shall be passed through to third parties on behalf of AgenTus without a valid invoice or other written documentation between the Parties evidencing such payment arrangement.

2.2Reimbursement of Expenses.  AgenTus shall reimburse Consultant for reasonable travel and other out-of-pocket expenses pre-approved by AgenTus in writing, and incurred by Consultant in performance of the Services and in accordance with AgenTus’ Travel & Expense Policy and Procedures, as may be amended from time to time by AgenTus, provided that Consultant shall have submitted to AgenTus written expense statements and other supporting documentation in a form that is reasonably satisfactory to AgenTus. AgenTus shall provide Consultant with a check for any amounts due under this Section 2.2 within forty-five (45) days after AgenTus receives satisfactory documentation.

2.3Independent Contractor.  Consultant is an independent contractor of AgenTus.  Consultant acknowledges and agrees that AgenTus will not provide Consultant with any benefits.  Without in any way limiting the generality of the foregoing, Consultant acknowledges and agrees that he or she has no right to participate in any AgenTus (or its Affiliates) equity plan(s).  Consultant is also responsible for the payment and the withholding of all applicable taxes, levies and/or duties applicable to any compensation or reimbursements paid to Consultant hereunder in accordance with all applicable laws, rules and regulations.

2.4No Additional Obligation/Fair Market Value.  Consultant acknowledges and agrees that the compensation payable hereunder represents AgenTus’ full and complete obligation for any and all Services to be rendered by Consultant under this Agreement.  Consultant further represents to AgenTus that the compensation paid hereunder represents fair market value for Consultant’s time and the Services hereunder and is consistent with fees paid to 

Page 2 of 10

 

Consultant for similar time and services provided by Consultant to others.  Both Parties acknowledge that the compensation is not determined in a manner that takes into account the volume or value of any future business that might be generated between the Parties.  In addition, Consultant and AgenTus acknowledge that nothing in this Agreement shall be construed to require Consultant to promote, purchase, prescribe, or otherwise recommend any AgenTus products being marketed or under development.

3.Term and Termination.

3.1Term.  This Agreement shall commence on the Effective Date and shall automatically renew for successive one month periods until either Party terminates the Agreement in accordance with the provisions of this Article 3.

3.2General Termination by AgenTus.  AgenTus may terminate this Agreement with or without cause upon seven (7) days prior written notice to Consultant with no further obligation to Consultant, other than payment of compensation in accordance with Article 2 for Services rendered in accordance with this Agreement prior to the date of such termination notice. 

3.3Immediate Termination by AgenTus.  In addition, AgenTus may terminate this Agreement immediately upon written notice to Consultant (or his/her legal representative) in the event (i) of the death or legal incapacity of Consultant or (ii) that Consultant is otherwise no longer able to perform the Services or (iii) if Consultant breaches or threatens to breach any provision of Sections 1.2, 1.3, 1.4, 7.3 or Articles 4, 5 or 6.

3.4Termination by Consultant.  In the event that AgenTus commits a material breach of its obligations under this Agreement, Consultant may terminate this Agreement upon fifteen (15) days prior written notice to AgenTus, unless the breach is cured within such fifteen (15) day notice period. 

3.5Survival.  The following provisions shall survive the expiration or termination of this Agreement: Articles 4, 5 and 6; Sections 1.2, 1.4, 7.3 through 7.10, and this Section 3.5.

4.Confidential Information.

4.1Definition of Confidential Information.  Confidential Information shall mean any technical or business information furnished by or on behalf of AgenTus to Consultant in connection with this Agreement or developed by Consultant in the course of performing the Services, regardless of whether such Confidential Information is in oral, electronic or written form.  Such Confidential Information may include, without limitation, trade secrets, know-how, inventions, technical data or specifications, testing methods, business or financial information, 

Page 3 of 10

 

research and development activities, product and marketing plans, and customer and supplier information.

4.2Obligations.  Consultant shall

(a)maintain all Confidential Information in strict confidence; and

(b)use all Confidential Information solely for the purpose of providing the Services as requested by AgenTus; and

(c)reproduce the Confidential Information only to the extent necessary for providing the Services as requested by AgenTus, with all such reproductions being considered Confidential Information;

(d)disclose the Confidential Information only as expressly permitted in order to perform the Services; and

(e)not disclose or publish any Confidential Information to any third party without the express prior written consent of AgenTus, in each case in AgenTus’ sole discretion.

4.3Exceptions.  The obligations of Consultant under Section 4.2 shall not apply to the extent that Consultant can demonstrate that certain information:

(a)was in the public domain prior to the time of its disclosure or development under this Agreement;

(b)entered the public domain after the time of its disclosure or development under this Agreement other than due to an act or omission by Consultant;

(c)was independently developed by Consultant prior to the time of its disclosure or development under this Agreement and without access to Confidential Information; or

(d)is or was disclosed to Consultant at any time prior to its disclosure or development under this Agreement, without restriction, by a third party having no fiduciary relationship with AgenTus and having no obligation of confidentiality with respect to such Confidential Information.

4.4Required Disclosures.  In addition Consultant may disclose Confidential Information to the extent necessary to comply with applicable laws or regulations, or with a court or administrative order, provided that Consultant (i) gives AgenTus prompt written notice of such requirement, (ii) takes all reasonable and lawful actions to obtain confidential treatment for such disclosure and, if possible, to minimize the extent of such disclosure, and (iii) discloses only the Confidential Information strictly required to comply with such legal obligation.

4.5Return of Confidential Information; Survival of Obligations.  Upon the termination of this Agreement, or earlier at the request of AgenTus, Consultant shall return to AgenTus all originals, copies, and summaries of documents, materials, and other tangible 

Page 4 of 10

 

manifestations of Confidential Information in the possession or control of Consultant.  The obligations set forth in this Article 4 shall remain in effect for a period of five (5) years after termination of this Agreement, except that the obligations of Consultant to return Confidential Information shall survive until fulfilled.  Consultant acknowledges and agrees that the Confidential Information is of extreme value to AgenTus, and any use or disclosure thereof other than as expressly allowed under this Agreement would cause irreparable harm to AgenTus for which AgenTus could obtain relief as contemplated in Section 7.9 of this Agreement, and that such unauthorized disclosure may represent Consultant’s violation of U.S. securities laws.

5.Developments; Third Party IP; Avoidance of Claims.

5.1Developments.  “Developments” shall mean any and all inventions, developments, data, discoveries, improvements, ideas, or concepts, and related documentation, and any other works of invention or authorship (whether or not patentable or copyrightable) which Consultant has conceived, discovered, developed, or reduced to practice or tangible medium in the course of providing the Services, or which arise from access to and/or use of Confidential Information, and any and all intellectual property rights in any of the foregoing.  Consultant shall promptly disclose to AgenTus any and all Developments.  Consultant acknowledges and agrees that all Confidential Information and Developments is and shall remain the exclusive property of AgenTus or the third party entrusting any Confidential Information to AgenTus.  Consultant shall and hereby assigns, conveys, and grants to AgenTus, all of his or her right, title, and interest in and to any and all Developments.  

5.4Third-Party Intellectual Property.  Consultant acknowledges that AgenTus does not desire to acquire any trade secrets, know-how, confidential information, or other intellectual property that Consultant may have acquired from or developed for any third party (“Third-Party IP”).  Consultant agrees that in the course of providing the Services, Consultant shall not improperly use or disclose any Third-Party IP. 

5.5Avoidance of Claims by Third-Parties.  Unless covered by an appropriate agreement between any third party and AgenTus, Consultant shall not engage in any activities or use any facilities, funds or equipment, in the course of providing Services, which could result in claims of ownership to any Developments by such third party. 

6.U.S. Foreign Corrupt Practices Act Compliance.  

6.1FCPA.  Consultant understands that AgenTus’ parent entity, Agenus Inc. (“Agenus”) is an issuer of securities in the United States and is subject to the provisions of the U. S. Foreign Corrupt Practices Act, 15 U.S.C. §§ 78m, 78dd-1 through 78dd-3 (“FCPA”).  This law prohibits making, promising or offering to make corrupt payments to foreign officials, political parties or candidates, or making payments to other persons who will offer or make payments to any of the aforementioned parties in order to obtain business, retain business or gain an improper advantage.  Consultant represents and warrants to AgenTus that Consultant is familiar with and understands the FCPA.  

6.2Representations.  Consultant represents and warrants to AgenTus that throughout the period in which Consultant provides Services to AgenTus, neither Consultant, nor any person 

Page 5 of 10

 

performing Services on behalf of Consultant will engage in any activity that could cause a violation of any provision of the FCPA by AgenTus.  Consultant represents and warrants that Consultant has not made, promised to make, or arranged for any third party to make any payments or gifts to foreign officials in connection with Consultant’s engagement by AgenTus.  Further, Consultant represents and warrants to AgenTus that Consultant has not violated any anti-corruption law and further that Consultant is not involved in, or the subject of, any investigation involving bribery, corruption or improper payments to foreign government officials, as defined in the FCPA.  Consultant agrees to update these representations and warranties on a periodic basis as required by AgenTus in a format prescribed by AgenTus.

6.3Notice of Violation.  Consultant agrees to notify AgenTus immediately in writing if Consultant or any person who is performing Services hereunder on behalf of Consultant is suspected of violating any anti-corruption law or becomes involved in, or a subject of, an investigation or law enforcement inquiry into possible improper payments to foreign officials or possible violations of anti-corruption laws.   Consultant further agrees to provide such notification if Consultant or any person performing Services hereunder on behalf of Consultant becomes involved in any action, suit, claim, investigation or proceeding that is pending, or to the knowledge of Consultant threatened, relating to a potential violation of any anti-corruption laws, including the FCPA.

6.4Audits.  Consultant agrees to grant AgenTus the right to audit Consultant’s books and records regarding the receipt and disposition of any payments made to Consultant by AgenTus, and Consultant further agrees to cooperate with AgenTus in connection with such audits.

6.5Material Provision.  It is agreed between Consultant and AgenTus that this Article 6 is deemed by the Parties to be a material provision of this Agreement.

 6.6AgenTus Policy.  Consultant has received a copy of AgenTus’ Policy on Improper Payments and Compliance with the FCPA (the “Policy”).  Consultant represents and warrants that Consultant has had the opportunity to review the Policy, understands the Policy, and will comply with it. 

7.Miscellaneous.

7.1Counterparts. This Agreement may be executed in counterparts, which, when taken together, shall constitute one agreement. If any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the Party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof.

7.2Assignment.  This Agreement may not be assigned by either Party without the prior written consent of the other Party, except that AgenTus may assign this Agreement to an affiliate or in connection with the merger, consolidation, or sale of all or substantially all of its business or assets relating to this Agreement.  This Agreement shall inure to the benefit of and be 

Page 6 of 10

 

binding upon the Parties and their respective lawful successors, assigns, heirs, and personal representatives.

7.3Insider Trading.  Consultant acknowledges that Consultant may receive material, non-public information about AgenTus (and potentially its Affiliates) and its business in the course of providing the Services, that this information must be maintained in strict confidence, and that the U.S. securities laws restrict trading on the basis of such information or providing such information to third parties who may trade on such information.

7.4Publicity.  Consultant consents to use by AgenTus of Consultant’s name and likeness in written materials or oral presentations to current or prospective customers, investors or others, provided that such materials or presentations accurately describe the nature of Consultant’s relationship with or contribution to AgenTus.

7.5Notices.   Any notice or other communication required or permitted hereunder shall be in writing and shall be deemed given (a) when delivered personally, (b) upon confirmation of delivery by email if sent during normal business hours, and otherwise on the next business day, (c) on the next business day after timely delivery to an overnight courier (postage prepaid), or (d) on the third business day after deposit in the United States mail (certified or registered mail return receipt requested, postage prepaid), to the addresses of the Parties set forth in the first paragraph of this Agreement, and in the case of correspondence to AgenTus, with a copy to “Legal Department” at the same address.  Either Party may change its designated address by notice to the other Party in the manner provided in this Section 7.5.

7.6Entire Agreement; Amendment.  This Agreement constitutes the entire agreement between the Parties with respect to the subject matter hereof and supersedes any and all prior or contemporaneous oral and prior written agreements and understandings.  This Agreement may be modified, amended, or supplemented only by means of a written instrument signed by both Parties.  Any waiver of any rights or failure to act in a specific instance shall relate only to such instance and shall not be construed as an agreement to waive any rights or fail to act in any other instance, whether or not similar.

7.7Governing Law.  This Agreement has been drafted in the English Language and the English language shall govern its interpretation.  This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware irrespective of any conflict of laws principles.

7.8Severability.  In the event that any provision of this Agreement shall, for any reason, be held to be invalid or unenforceable in any respect, such invalidity or unenforceability shall not affect any other provision hereof, and this Agreement shall be construed as if such invalid or unenforceable provision had not been included herein.  If any provision hereof shall, for any reason, be held by a court to be excessively broad as to duration, geographical scope, activity, or subject matter, it shall be construed by limiting and reducing it to make it enforceable to the extent compatible with applicable law as then in effect.  To the extent this Agreement may be construed in accordance with the laws of any state that limits the assignability to AgenTus of certain Developments, the provisions of this Agreement shall be modified to conform to such 

Page 7 of 10

 

state limitation while most closely effectuating the original intention of the Parties (e.g., by providing for fully paid up license rights, or the like).

7.9Equitable Relief.  Consultant acknowledges that the restrictions contained in this Agreement are necessary for the protection of the business and goodwill of AgenTus and are reasonable for such purpose.  Consultant agrees that any breach or threatened breach of his or her obligations under this Agreement will cause irreparable harm to AgenTus.  Therefore, in addition to any other remedies that may be available to AgenTus, AgenTus may apply for and obtain immediate injunctive relief in any court of competent jurisdiction to restrain the breach or threatened breach of, or otherwise to specifically enforce, any obligations of Consultant under this Agreement.

7.10Massachusetts Information Security Regulations Compliance. Massachusetts Information Security Regulations, 201 Code of Mass. Regs. 17.00 et seq. (the “IS Regulations”) mandate procedures to safeguard the “Personal Information,” as defined in the IS Regulations, of Massachusetts residents. Because Consultant may have access to the Personal Information of AgenTus’ employees, contractors, business associates, or customers who are Massachusetts residents (“Protected Information”), the IS Regulations require Consultant to certify compliance with the IS Regulations. Accordingly, Consultant agrees that, as long as Consultant has access to or maintains copies of Protected Information Consultant will: (a) comply with the IS Regulations with respect to the Protected Information, (b) promptly notify AgenTus of any suspected or actual data breach involving Protected Information, and (c) cooperate with AgenTus to investigate and remediate any suspected or actual data breach involving Protected Information.

7.11Whistleblower Notice.  Pursuant to 18 USC § 1833(b), an individual may not be held criminally or civilly liable under any federal or state trade secret law for disclosure of a trade secret: (i) made in confidence to a government official, either directly or indirectly, or to an attorney, solely for the purpose of reporting or investigating a suspected violation of law; and/or (ii) in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.  Accordingly, the Parties to this Agreement have the right to disclose in confidence trade secrets to Federal, State, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The Parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.

 

[The remainder of this page is intentionally left blank]

Page 8 of 10

 

IN WITNESS WHEREOF, the Parties each have caused this Agreement to be executed by their duly respective authorized representative as of the Effective Date. 

 

	
AGENTUS THERAPEUTICS, INC.
	
CONSULTANT

 

/s/ Bruno Lucidi_________                                        /s/ Robert B. Stein           

	
Name: Bruno Lucidi
	
Name: Robert B. Stein

Title:   CEO

 

            

Page 9 of 10

 

  

Attachment 1

Consulting Services

THE UNDERSIGNED HEREBY ACKNOWLEDGE AND AGREE THAT THIS ATTACHMENT IS INCORPORATED BY REFERENCE INTO, AND SUBJECT TO THE PROVISIONS OF, THAT CERTAIN CONSULTING AGREEMENT BETWEEN THE PARTIES DATED AS OF THE DATE HEREOF (THE “AGREEMENT”).

Description of Services

During the Term of the Agreement, Consultant shall provide up to twenty (20) hours of scientific guidance and advisory services to AgenTus Therapeutics, Inc. per week (“AgenTus”).

For the avoidance of doubt, general consulting Services specifically excludes any Services provided pursuant to any other Attachment.

Compensation

In exchange for the timely completion of Services during the Term, AgenTus shall pay Consultant $10,416.67 per month.

Payment of Compensation shall be made within 15 days following the end of each month.  In accordance with Section 2.2 (Reimbursement of Expenses) of the Agreement, AgenTus agrees to reimburse Consultant for pre-approved, reasonable and necessary out-of-pocket expenses incurred by Consultant in performance of the Services.

	
AGENTUS THERAPEUTICS, INC.
	
CONSULTANT

                                                                    

/s/ Bruno Lucidi_____________/s/ Robert B. Stein________

	
Name: Bruno Lucidi
	
Name: Robert B. Stein

Title:  CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00289-of-00352.parquet"}]]